This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Ticaros Co., Ltd.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Hye-Ran Yeon: Innovator in Chimeric Antigen Receptor Technology
Introduction
Hye-Ran Yeon is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of immunotherapy, particularly through his innovative work on chimeric antigen receptors (CAR). His research focuses on enhancing the efficacy of immune cell therapies for cancer treatment.
Latest Patents
Hye-Ran Yeon holds a patent for an "Immune synapse-stabilizing chimeric antigen receptor (CAR) T cell." This invention introduces a novel chimeric antigen receptor that incorporates a CD99 region, which plays a crucial role in stabilizing immune synapses. The CD99-based CAR-T cells demonstrate a remarkable ability to form stable immune synapses with tumor cells, surpassing the performance of conventional CAR-T cells. This advancement is expected to improve therapeutic efficiency in cancer treatments.
Career Highlights
Hye-Ran Yeon is associated with Ticaros Co., Ltd., where he continues to develop innovative solutions in the field of immunotherapy. His work is pivotal in advancing the understanding and application of CAR technology in clinical settings.
Collaborations
Hye-Ran collaborates with notable colleagues, including Eun-Young Choi and Kyungho Choi. Their combined expertise contributes to the ongoing research and development efforts at Ticaros Co., Ltd.
Conclusion
Hye-Ran Yeon's contributions to the field of immunotherapy through his innovative chimeric antigen receptor technology are noteworthy. His work holds promise for enhancing cancer treatment options and improving patient outcomes.